Search details
1.
Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatment.
Antimicrob Agents Chemother
; : e0000824, 2024 May 20.
Article
in English
| MEDLINE | ID: mdl-38767383
2.
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
N Engl J Med
; 378(10): 911-923, 2018 Mar 08.
Article
in English
| MEDLINE | ID: mdl-29514030
3.
The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non-alcoholic fatty liver disease.
J Gastroenterol Hepatol
; 36(10): 2952-2959, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34129252
4.
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
BMC Infect Dis
; 16: 393, 2016 08 09.
Article
in English
| MEDLINE | ID: mdl-27506549
5.
Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study.
J Gastroenterol Hepatol
; 31(11): 1874-1881, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-26997582
6.
Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis.
J Gastroenterol Hepatol
; 31(10): 1757-1765, 2016 Oct.
Article
in English
| MEDLINE | ID: mdl-26992248
7.
Three-day versus five-day somatostatin infusion combination with endoscopic variceal ligation in the prevention of early rebleeding following acute variceal hemorrhage: A randomized controlled trial.
Hepatol Res
; 45(13): 1276-82, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-25676742
8.
Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection.
J Gastroenterol Hepatol
; 30(1): 184-91, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-24995515
9.
Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy.
J Med Virol
; 86(8): 1360-5, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24777626
10.
Efficacy and safety of pinaverium bromide as an add-on therapy in refractory dyspepsia: A randomized controlled trial.
JGH Open
; 8(3): e13051, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38486875
11.
A new biomarker panel for differential diagnosis of cholangiocarcinoma: Results from an exploratory analysis.
Int J Biol Markers
; 39(2): 107-117, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38549363
12.
Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling.
J Virol
; 86(16): 8581-91, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22674974
13.
Clinical features and prognostic factors for liver cancer from a referral center in northern Thailand.
J Med Assoc Thai
; 96(5): 531-7, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23745306
14.
Secondary Iron Overload and the Liver: A Comprehensive Review.
J Clin Transl Hepatol
; 11(4): 932-941, 2023 Aug 28.
Article
in English
| MEDLINE | ID: mdl-37408825
15.
Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma.
Front Oncol
; 13: 1213898, 2023.
Article
in English
| MEDLINE | ID: mdl-37920152
16.
Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study.
J Hepatol
; 56(6): 1247-53, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22326470
17.
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study.
Hepatol Commun
; 6(4): 679-691, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34796691
18.
Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
World J Gastroenterol
; 28(29): 3917-3933, 2022 Aug 07.
Article
in English
| MEDLINE | ID: mdl-36157551
19.
Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B.
Liver Int
; 31(5): 676-84, 2011 May.
Article
in English
| MEDLINE | ID: mdl-21457439
20.
Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.
J Gastroenterol Hepatol
; 26(7): 1182-8, 2011 Jul.
Article
in English
| MEDLINE | ID: mdl-21410752